Replies to post #143412 on Biotech Values

[dav1234]

agreed, a bit bearish..if ACHN dips further i may add ,really would like to know reason she left...a benign personal reason will do,lol.

[dav1234]

Baird says the weakness in Achillion (ACHN -4.5%) is a buying opportunity , following the announcement of the resignation of its Chief Medical Officer. The firm notes that ACHN is in a "catalyst rich period" with a solid pipeline, and is confident the chief Scientific Officer will be able to assume the CMO's duties without any significant disruption

[DewDiligence]

Almost a year later, ACHN names a CMO replacement for Elizabeth Olek:

http://finance.yahoo.com/news/achillion-appoints-dr-david-apelian-100000413.html